Skip to main content
. 2017 Aug 24;8:63–65. doi: 10.1016/j.ebcr.2017.08.001

Table 1.

Demographic and clinical characteristics.

Sex, females: n, % 4, 44.4%
Age, years: mean (SD) 46.9 (10.3)
Age at onset, years: mean (SD) 13.2 (6.3)
Number of prior ASDs: median (IQR) 3 (3–5)
ASDs combined to LCM (n) VPA (6), LEV (4), LTG (1)
VPA dose, mg: median (IQR)a 1250 (1050–1450)
Number of GTCS/6 months pre-LCM: median (IQR) 2 (2–3)
a

Excluding patients not taking VPA.